Entity

Time filter

Source Type

Not Found, Italy

Trademark
Herniamesh S.R.L. | Date: 2007-12-04

SURGICAL PROSTHESES FOR URINARY INCONTINENCE AND UROGYNECOLOGY.


Trademark
Herniamesh S.R.L. | Date: 2008-12-16

SURGICAL, MEDICAL, DENTAL AND VETERINARY APPARATUS AND INSTRUMENTS, NAMELY, SURGICAL MESHES MADE OF MONOFILAMENT POLYPROPYLENE USED IN THE REPAIR OF HERNIAS AND IN THE TREATMENT OF THE PELVIC FLOOR REPAIR; ARTIFICIAL LIMBS, EYES AND TEETH; ORTHOPAEDIC ARTICLES, NAMELY, RIGID MESH FOR USE IN THE HERNIA REPAIR.


Trademark
Herniamesh S.R.L. | Date: 2010-02-16

SURGICAL APPARATUS AND INSTRUMENTS, NAMELY, SURGICAL PROSTHESES FOR URINARY INCONTINENCE AND UROGYNECOLOGY.


Grant
Agency: Cordis | Branch: H2020 | Program: SME-1 | Phase: NMP-25-2014-1 | Award Amount: 71.43K | Year: 2015

3L-HeCoMe aims to provide efficient and effective industrial solutions to innovate the production processes and products for hernia containment. Ventral hernia repairs in Europe are 400.000/year, but post-operative complications still occur, namely recurrence due to prosthetic displacement and adhesions between viscera and prosthetic surfaces. Considering estimated costs for each ventral hernia repair in Europe, costs due only to recurrence amount to 36.732.000 /year. The main aim of 3L-HeCoMe Feasibility Study(FS) is the development of an innovative process supported by enabling technologies derived from other applications and by the use of advanced materials to produce a unique medical device for the Intraperitoneal Treatment of Abdominal Wall Hernias (IPTAWH). The produced IPTAWH medical device (IPTAWH-MD) aims at preventing post-surgery problems and avoiding, or decreasing, use of mechanical surgery instruments for the mesh fixation. The IPTAWH-MD will reduce the surgical duration and costs, thanks to the following characteristics: chemical adhesive properties to parietal tissues anti-adhesion properties to viscera adequate mechanical properties, partial bioresorption. FS objectives: investigate technical development, process customization and applicability qualify 3L-HeCoMe process production output and constituting materials assess market potential and penetration routes Final users are surgeons oriented towards simplified, faster and mininvasive procedure, in the global market, which amounts to about USD 500 million and has an estimated CAGR of 7.5%, bringing to 700 million in 2019. The resulting MD will substitute actual products, giving a solid position to the SME in global markets and increasing the income, with potential sales of 259.000 452.000 /year from year 1 to 5. 3L-HeCoMe addresses societal issues avoiding hernia operation recurrence, improving quality of life of patients by reducing hospitalization and reducing healthcare


Trademark
Herniamesh S.R.L. | Date: 2006-01-30

Surgical apparatus and instruments, surgical prostheses, orthopedic articles.

Discover hidden collaborations